CPHRF News and Press, Companhia Siderurgica Paulista Nova Cosipa From 03/17/22

Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q4 GAAP EPS of C$0.11. Revenue of C$5.9M (-3.3% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.11, revenue of C$5.9M

The following slide deck was published by Cipher Pharmaceuticals Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Cipher Pharmaceuticals Inc. 2022 Q1 - Results - Earnings Call Presentation

Cipher Pharmaceuticals Inc. (CPHRF) Q3 2021 Earnings Conference Call November 12, 2021, 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer Conference Call Participants Presentation Operator Good morning, ladies and gentlemen. ...

Cipher Pharmaceuticals (OTCPK:CPHRF): Q3 GAAP EPS of $0.03 misses by $0.06. Revenue of $4.5M (-8.2% Y/Y) misses by $1.34M. Press Release For further details see: Cipher Pharmaceuticals EPS misses by $0.06, misses on revenue

Cipher Pharmaceuticals Inc. (CPHRF) Q2 2021 Earnings Conference Call August 13, 2021, 08:30 AM ET Company Participants Craig Mull - Interim CEO Scott Langille - CFO Conference Call Participants Doug Loe - Leede Jones Gable Presentation Operator Good morning, ladies and gentlemen. Thank you fo...

Cipher Pharmaceuticals Schedules Q2 2021 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , Aug. 9, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced it will release its Q2 2021 financial r...

Cipher Pharmaceuticals, Inc. (CPHRF) Q1 2021 Results Earnings Conference Call May 14, 2021, 08:00 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Scott Langille - Chief Financial Officer Conference Call Participants Douglas Loe - Leede Jones Gable Inc. Presentation Ope...

Cipher Pharmaceuticals (CPHRF): Q1 Non-GAAP EPS of $0.10; GAAP EPS of $0.05 beats by $0.14.Revenue of $5.4M (-8.5% Y/Y) beats by $0.19M.Press Release For further details see: Cipher Pharmaceuticals EPS beats by $0.14, beats on revenue

Cipher Pharmaceuticals Reports First Quarter 2021 Financial Results Canada NewsWire Generates Adjusted EBITDA of $3.6 million and EPS of $0.05 ( CDN$0.6 1 ) Excluding legal provision EPS was $0.10 (CDN$0.12) OAKVILLE, ON , ...

Cipher Pharmaceuticals Schedules Q1 2021 Earnings Release and Conference Call Canada NewsWire OAKVILLE, ON , May 5, 2021 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (" Cipher " or "the Company ") today announced it will release its Q1 2021 ...